213. CANCER DU REIN METASTATIQUE : CHOIX DANS...

217. LASER DOPÉS AU THULIUM : AVANTAGES ET PERSPECTIVES DANS LA PRISE EN CHARGE DE CALCULS URINAIRES - DR PANTHIERQu'est-ce qu'un laser thulium ?Quels sont les avantages du laser thulium fibré par rapport au laser holmium-YAG ?Quels sont les lasers recommandés en 2024 pour traite ...  Show more

216. IDENTIFICATION ET PRISE EN CHARGE DES MALADIES LITHIASIQUES HEREDITAIRES - PROFESSEUR HAYMANNQuand faut-il suspecter les maladies lithiasiques héréditaires ? Comment les identifier ? De quels outils dispose t-on et quelles sont les recommandations diététiques et thérapeutiqu ...  Show more

Join experts Drs Benjamin Schlechter and Diane Saverese as they discuss systemic therapy for advanced colorectal cancer. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/988974). The topics and discussions are planned ...  Show more

During this episode, Dr. Thomas Seisen (FR), an associate member on the EAU Guidelines Panel for Non-Muscle Invasive Bladder Cancer,  answers questions about metastatic upper urothelial cancer (UTUC) treatment options in the 2022 guidelines:

Join Drs Benjamin Schlechter and Jeff Meyerhardt as they discuss the latest breakthroughs in adjuvant chemo for CRC and share their decision-making in real-world scenarios. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ...  Show more

This week, we incorporate medical oncology back into our discussion with our Radiation Oncologist, Dr. Sanford, and our Surgical Oncologist, Dr. Bailey. We discuss how we approach the management of localized rectal cancer. Note that we will be heavily building off our discussi ...